This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kral, M. C.
Right arrow Articles by Hynd, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kral, M. C.
Right arrow Articles by Hynd, G. W.
Related Collections
Right arrow Blood
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
PEDIATRICS Vol. 112 No. 2 August 2003, pp. 324-331

Transcranial Doppler Ultrasonography and Neurocognitive Functioning in Children With Sickle Cell Disease

Mary C. Kral, PhD*, Ronald T. Brown, PhD*,{ddagger}, Paul J. Nietert, PhD§, Miguel R. Abboud, MD*, Sherron M. Jackson, MD* and George W. Hynd, EdD||

* Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina
{ddagger} College of Health Professions, Medical University of South Carolina, Charleston, South Carolina
§ Center for Health Care Research, Medical University of South Carolina, Charleston, South Carolina
|| Office of Research and External Affairs, University of Georgia, Athens, Georgia


   ABSTRACT
TOP
 ABSTRACT
METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Objective. We examined the relationship between cerebral blood flow velocity, measured by transcranial Doppler (TCD) ultrasonography, and neurocognitive functioning.

Methods. Participants were 60 children who had sickle cell disease (HbSS) and had no documented history of stroke. Children were classified according to Stroke Prevention Trial in Sickle Cell Anemia criteria (normal, conditional, and abnormal), and their performance was compared on measures of intellectual abilities, academic achievement, sustained attention/concentration, executive function, and parent and teacher ratings of executive function.

Results. Children with abnormal TCD values performed more poorly than children with conditional TCD values on measures of verbal intelligence and executive function. Children with conditional TCD values performed more poorly than children with normal TCD values on measures of sustained attention/concentration and executive function. TCD values also were a significant predictor of auditory working memory in exploratory analyses.

Conclusions. Our findings support the hypothesis that neurocognitive functions subserved by the frontal systems (eg, sustained attention/concentration and executive function) seem to be the most useful indices of progressive cerebrovasculopathy in children with HbSS disease.

Key Words: transcranial Doppler ultrasonography • sickle cell anemia • neurocognitive functioning • pediatric

Abbreviations: SCD, sickle cell disease • CVA, cerebrovascular accident • MRI, magnetic resonance imaging • CNS, central nervous system • TCD, transcranial Doppler • STOP, Stroke Prevention Trial in Sickle Cell Anemia • Vmean, mean velocity • WASI, Wechsler Abbreviated Scale of Intelligence • VIQ, verbal IQ • BRIEF, Behavior Rating Inventory of Executive Function • MANCOVA, multivariate analyses of covariance • ANCOVA, analyses of covariance • SD, standard deviation

Perhaps some of the most devastating outcomes of pediatric sickle cell disease (SCD) are neurologic complications. Cerebrovascular accident (CVA) constitutes a leading cause of morbidity and mortality, occurring most frequently in children with the HbSS genotype at an estimated incidence of 4% to 8%.1,2 Neurocognitive sequelae of clinically apparent CVA in children with HbSS are characterized by pervasive impairments, including decrements in general intellectual function, language and verbal abilities, visual-motor and visual-spatial processing, memory, academic achievement, and sustained attention/concentration.3–7 Deficits in the processing of subtle prosodic information also have been documented.8

Children with SCD also may show evidence of neurologic pathology and associated neurocognitive deficits before signs and symptoms become apparent. As many as 11% to 17% of children who have HbSS disease and are otherwise asymptomatic have silent cerebral infarcts, lesions of infarction or ischemia identified on brain magnetic resonance imaging (MRI).9–11 Silent cerebral infarcts are most likely accounted for by chronic hypoxia in the microvasculature ensuing from progressive disease in the major cerebral arteries.10,12,13 Early investigators of the neuropsychological correlates of pediatric SCD provided data suggesting that children who have SCD with no known history of stroke were at increased risk for learning impairments.14–18 For example, children with SCD demonstrated poorer performance on measures of reading decoding and sustained attention/concentration than healthy sibling comparison control subjects. The results of these investigations, however, were variable, making comparisons across studies difficult.

More recent investigations have addressed the neurocognitive sequelae of silent infarcts in children with SCD by comparing the performance of MRI-defined groups.3,4,12,19–21 These studies demonstrated that the neuropsychological deficits associated with silent infarcts are typically less severe than those deficits associated with overt stroke. These results also lend support for the importance of measures of attention and executive function for the identification of patients with silent cerebral infarcts.19 In fact, Brown et al4 provided important evidence for group differences in the areas of attention and executive function; children with silent cerebral infarct demonstrated similar attentional impairments as children with a history of overt CVA. This finding was explained by the location of central nervous system (CNS) pathology. For the entire sample, the highest frequency of damage was overwhelmingly localized in the frontal lobes, present in 93% of children in the overt stroke and silent cerebral infarct groups.

The extant neurologic and neuropsychological literatures support a disease-specific model of neurocognitive decline in children with HbSS disease. Neurocognitive functions subserved by the frontal systems (eg, tasks of sustained attention/concentration and executive function) seem to be particularly vulnerable to the deleterious effects of progressive cerebrovasculopathy. In fact, these data also are consistent with the finding of pervasive frontal cortex blood flow dysfunction in adults with HbSS.22 The advent of transcranial Doppler (TCD) ultrasonography allowed for the reliable detection of vasculopathy, previously seen only on angiography or neuropathological examination.23,24 Furthermore, this technique led to the identification of asymptomatic children who have SCD and are at highest risk for cerebral infarction.25–27 In this context, it would be important to investigate the neuropsychological correlates of TCD ultrasonography in the pediatric SCD population.

Our study sought to extend the findings of the Stroke Prevention Trial in Sickle Cell Anemia (STOP).28,29 This study represents the first known investigation to examine the association between cerebral blood flow velocity, as measured by TCD ultrasonography, and neurocognitive functioning in children with sickle cell anemia (HbSS). Previous studies generally compared groups (eg, stroke versus nonstroke groups), which did not allow for examination of the progressive nature of cerebrovasculopathy in this population of children. In this investigation, we examined the continuum of disease severity using TCD data as indices of disease severity. We also examined the usefulness of TCD diagnostic groupings in terms of neurocognitive functioning. We hypothesized that relative to children who displayed TCD ultrasonography values that were within the normal range (<170 cm/sec), children with values in the conditional (170–200 cm/sec) and abnormal ranges (>200 cm/sec) would exhibit poorer neurocognitive performance. Finally, we hypothesized that measures of attention/concentration and executive function would be more sensitive to the identification of TCD ultrasonography in the pathologic range, relative to more global indices of intelligence and academic achievement.


   METHODS
TOP
 ABSTRACT
 METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Participants
Participants were 60 children and adolescents who had HbSS and were receiving treatment at 2 major university-affiliated teaching hospitals in the southeastern part of the United States. These hospitals primarily serve individuals of lower socioeconomic status. Most of our sample, then, was composed of individuals of fairly low socioeconomic status, which is characteristic of other investigations of children and adolescents with SCD.4,8 Approximately 600 children with SCD were followed at each center during the 18-month data collection period between 2000 and 2002. Children and adolescents who met study criteria were referred to the investigators by pediatric hematologists for evaluation of their neurocognitive functioning. Patients who were between the ages of 6 years, 0 months and 16 years, 11 months and had a confirmed diagnosis of HbSS and also were participants in the larger, multicenter STOP investigation of TCD28,29 were included for participation in this investigation. Patients were excluded from the study when they had a history of birth complications, traumatic brain injury, known CVA, or major chronic illness other than SCD. Five prospective participants who were recruited for participation in this investigation refused study enrollment because of transportation difficulties (n = 2) and concerns regarding school absence (n = 3).

After approval from the institutional review boards of both participating institutions, informed consent was obtained from the participants’ caregivers and assent was obtained from children 12 years of age and older. Demographic information was obtained through a questionnaire, and medical information was obtained from computerized databases at both institutions. For each participating child, laboratory data (eg, hematocrit) obtained closest in time to the neuropsychological evaluation were recorded from the computerized database. Caregivers also provided written consent to obtain information from the teachers of participating children. Educational history, including grade retention, special education placement, and behavioral functioning, was obtained through a questionnaire and behavior rating scales completed by each participating child’s teacher. Caregivers were provided with a written report of the results of the neuropsychological testing for their child.

TCD Methods
TCD studies of blood flow velocity in the basal cerebral arteries were performed by a trained technician, as detailed by Adams et al.28 Velocities in the proximal middle cerebral arteries and distal internal carotid arteries and bifurcation of the internal carotid arteries were recorded. The highest time-averaged mean velocity (Vmean) among these recordings was used in the statistical analyses. Following the guidelines of the STOP trial, participants were assigned to the normal TCD group when the highest Vmean was <170 cm/sec (n = 25). Participants were assigned to the conditional group when the highest Vmean was between 170 and 200 cm/sec (n = 15). Participants were assigned to the abnormal group when the highest Vmean exceeded 200 cm/sec (n = 20). TCD studies for participants in the normal and conditional categories were obtained within 6 months of neuropsychological testing. Because of the relative infrequency of abnormal TCD findings, participants who had abnormal TCD studies within a 5-year period before neuropsychological testing were enrolled. As part of the STOP protocol, these patients also were receiving chronic blood transfusions for primary stroke prevention.

Neurocognitive Battery
On the basis of the literature on neurocognitive functioning in children with SCD,3,4,19,21 a neurocognitive battery was selected to assess 5 domains of functioning: general intellectual abilities, academic achievement, sustained attention/concentration, executive function (eg, working memory), and parent and teacher behavior ratings of executive function. Each child was individually administered the battery of measures described next.

Intellectual Functioning
Measures of intelligence were obtained using the Wechsler Abbreviated Scale of Intelligence (WASI).30 The WASI is composed of those subtests on traditional Wechsler scales that have demonstrated the highest loadings (eg, >0.70) on g or general intellectual functioning.31–33 The WASI allows for assessment of verbal IQ (VIQ), performance, and full-scale intellectual functioning. These age-referenced standard scores were used in the statistical analyses.

Academic Achievement
Measures of academic achievement were obtained using the subtests that compose the Broad Reading and Broad Math composites of the Woodcock-Johnson Psycho-Educational Battery: Tests of Achievement-Revised.34 Broad Reading consists of the Letter-Word Identification subtest, which assesses correct pronunciation of isolated letters and words of graded difficulty, and the Passage Comprehension subtest, which measures reading comprehension. Broad Mathematics consists of the Calculation subtest, which assesses written calculations, and the Applied Problems subtest, which assesses skill in analyzing and solving practical problems in mathematics. Broad Reading and Broad Math age-referenced standard scores were used in the statistical analyses.

Measures of academic attainment also were obtained. At study enrollment, participant caregivers provided information on each child’s academic history, including whether the child had a grade retention and/or special education placement. Grade retention was defined as a child repeating a grade in school as a result of either lack of educational progress or excessive school absenteeism secondary to SCD complications. Special education placement was defined as receipt of special education services either in the regular education classroom (eg, 504 plan) or in an alternative classroom placement (eg, resource classroom, self-contained classroom).

Sustained Attention/Concentration
The Conners’s Continuous Performance Test II35 is a standardized, well-normed computerized task designed to assess visual sustained attention/concentration. During this 14-minute task, the examinee is instructed to respond to target stimuli on a computer screen and inhibit responses to nontarget stimuli. A number of computer-generated parameters yield information about inattention and impulsivity. Age-referenced T scores for omission errors, commission errors, reaction time, and response time variability were used in the statistical analyses.

Executive Function
The Numbers Backward and Picture Locations subtests from the Children’s Memory Scale36 provided measures of auditory and visual working memory, respectively. Working memory, an executive function, enables an individual to hold information in mind for the purpose of multistep problem solving. Numbers Backward requires mental manipulation of a string of numbers that are repeated backward. Picture Locations requires correct location of a previously exposed series of picture stimuli. Both measures assess span of working memory as the number of stimuli become increasingly longer as the tests progress. The composite score for Attention/Concentration on the Children’s Memory Scale, which includes Numbers Backward and Picture Locations, demonstrates a high correlation (0.73) with the Freedom From Distractibility Index of the Wechsler Intelligence Scale for Children III, a purported measure of working memory.36,37 Numbers Backward and Picture Locations yield age-referenced scaled scores, which were used in the statistical analyses.

The Trail Making Test38 is a paper-pencil test designed to assess focused attention, psychomotor speed, sequencing, mental flexibility, and visual search. Scoring is expressed in terms of the time in seconds required to complete parts A and B of the task. Part B, which requires set shifting (ie, executive function), has effectively differentiated the performance of children with SCD without CNS pathology from the performance of children with silent cerebral infarction.4 Performance on part B, time to completion, was used in the statistical analyses.

Parent and Teacher Ratings of Executive Function
Participant parents and teachers were asked to complete a behavior rating scale designed to assess executive functions in the home and school environments. The Behavior Rating Inventory of Executive Function (BRIEF)39 is composed of 86 items designed to assess various aspects of executive function, including ability to inhibit emotional and behavioral responses, cognitive flexibility, working memory, planning and organization skills, and initiative. Data support the reliability, internal consistency, and construct validity of this instrument. The BRIEF yields age-referenced T scores. The Behavioral Regulation Index, Metacognition Index, and Global Executive Composite T scores from the parent and teacher questionnaires were used in the statistical analyses.

Data Analyses
A series of separate 1-way multivariate analyses of covariance (MANCOVAs), using the general linear model, was performed for each of the neurocognitive domains (measures of intellectual functioning, academic achievement, sustained attention/concentration, executive function, and parent and teacher ratings of executive function). Group assignment based on TCD findings served as the independent variable (normal: <170 cm/sec; conditional: 170–200 cm/sec; and abnormal: >200 cm/sec). Given the modest correlation between hematocrit and some of the dependent variables that were of interest, hematocrit served as a covariate.a Also, hematocrit served as a covariate to control for the effects of transfusion in the abnormal TCD group. These analyses, which treated TCD data as a categorical variable, were conducted to determine whether neurocognitive performance differed across the 3 categories of TCD diagnostic groupings, controlling for the differential effect of hematocrit. Thus, 5 MANCOVAs were performed. Significant multivariate tests were followed by univariate analyses of covariance (ANCOVAs), again using hematocrit as a covariate. Fischer’s least significant difference planned contrasts were performed on any dependent measure for which there was a significant ANCOVA. The a priori {alpha} level was set at 0.05.

A series of exploratory multiple regression analyses, using the general linear model, were conducted to examine the relationship between cerebral blood flow velocity and neurocognitive functioning. Participants who were receiving transfusions were removed from the larger sample, to control for the potential confounding effect of this treatment condition (revised N = 44). In these analyses, the predictor variable of TCD was treated as a continuous variable. Age, gender, and hematocrit also were entered into each regression model to explore the extent to which these variables contributed to the linear relationship between cerebral blood flow velocity and neurocognitive functioning. Standardized test scores for each of the 5 neurocognitive domains served as the dependent variables.


   RESULTS
TOP
 ABSTRACT
 METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Of the participants (N = 60), 43.3% were male (n = 26) and 56.7% were female (n = 34). The mean age was 121.02 months (standard deviation [SD]: 31.34; range: 73.0–192.0 months). Grades in school ranged from kindergarten to 10th, with a mean of 3rd grade (mean: 3.76; SD: 2.45). Most children were served in the regular education classroom (60%; n = 36), and 40% (n = 24) were receiving special education services (eg, resource or self-contained classroom placements). The highest time-averaged TCD Vmean ranged from 92 to 276 cm/sec (median: 175.00; SD: 41.85). The majority of these TCD values were found in the proximal middle cerebral artery (59.3%; n = 35); however, 15.3% were obtained in the distal internal carotid artery (n = 9), and 25.4% were obtained in the bifurcation of the internal carotid artery (n = 15). Just more than half of the values for the highest time-averaged Vmean were obtained on the left side (54.2%; n = 32), compared with 45.8% of the values obtained on the right side (n = 27). Descriptive data regarding the relationship of participant to caregiver, caregiver education, and family income are provided in Table 1.


View this table:
[in this window]
[in a new window]
  		TABLE 1. Demographic Characteristics and Illness Severity

 
Table 1 presents the participant age and gender, caregiver’s education, family income, and illness severity data (highest time-averaged TCD Vmean reading and hematocrit) for each of the 3 TCD diagnostic groups. Differences were found for the demographic variable of gender; significantly more girls were in the conditional and abnormal TCD diagnostic groups, ({chi}2 = 6.24, P < .05). In addition, the groups differed in terms of special education placement. As expected, significantly more children in the abnormal group were receiving special education services, compared with the normal and conditional groups ({chi}2 = 9.38, P < .01). Although the comparison did not reach statistical significance, a trend was found toward increasing grade retention as a function of TCD group membership. A greater frequency of grade retention was found with more impaired TCD values. No differences were found for the other demographic variables.

A significant group difference was found for the highest time-averaged TCD Vmean (F(2,56) = 156.02, P < .001), consistent with the objectively defined TCD diagnostic groups. Post hoc analyses revealed that the highest time-averaged Vmean was higher in the conditional group than in the normal group (P < .001) and higher in the abnormal group than in the conditional group (P < .001). In contrast, group comparisons in terms of hematocrit did not reach significance. An examination of the means showed that the abnormal group, in fact, had a slightly higher mean value for hematocrit, compared with the normal and conditional groups. This difference is likely accounted for by the treatment that this group received; only children in the abnormal group were receiving chronic blood transfusions for primary stroke prevention.

Multivariate Analyses
The results of a 1-way MANCOVA on the intellectual functioning domain yielded a statistically significant main effect (Wilks’ {lambda} F[2,54] = 2.73, P < .05). Separate ANCOVAs were performed on each of the dependent measures, and a statistically significant effect was revealed for the WASI VIQ composite score (F[2,55] = 3.75, P < .05). Post hoc analyses revealed that the conditional group obtained significantly higher VIQs compared with the abnormal group (P < .01; Table 2).


View this table:
[in this window]
[in a new window]
  		TABLE 2. Means and SDs for Dependent Measures (N = 60)

 
The results of the 1-way MANCOVA for the sustained attention/concentration domain also yielded a trend toward a significant main effect (Wilks’ {lambda} F[2,55] = 1.84, P = .056). Although this effect was not statistically significant at the a priori {alpha} level, because of the exploratory nature of this investigation we elected to conduct ANCOVAs. A significant main effect for the Continuous Performance Test Hit Reaction Time (F[2,55] = 3.58, P < .05) and the Continuous Performance Test Variability score (F[2,55] = 3.16, P = .05) was revealed. Post hoc analyses revealed that the conditional group performed more poorly than the normal group for both reaction time (P < .05) and variability (P < .05).

A statistically significant main effect (Wilks’ {lambda} F[2,43] = 2.57, P < .05) also was demonstrated in the 1-way MANCOVA on the executive function domain. Separate ANCOVAs revealed a significant main effect for Trails B, time to completion score (F[2,44] = 5.99, P < .01). Post hoc analyses indicated that both the normal and the abnormal groups completed this test more rapidly than the conditional group (P < .01).

The results of the 1-way MANCOVA on parent and teacher ratings of executive function (BRIEF) yielded a statistically significant main effect (Wilks’ {lambda} F[2,53] = 2.17, P < .05). Separate ANCOVAs yielded a significant main effect for the parent BRIEF Behavioral Regulation Index (F[2,54] = 5.19, P < .01). Post hoc analyses indicated that parents rated the abnormal group as more impaired in behavioral regulation relative to the conditional group (P < .01). In addition, a significant effect was revealed for the teacher BRIEF Metacognition Index (F[2,55] = 3.48, P < .05). Post hoc analyses revealed that teachers rated children in the abnormal group as more impaired in metacognitive skills relative to children in either the normal (P < .05) or conditional (P < .05) groups.

Regression Analyses
A series of exploratory multiple regression analyses were computed for each of the dependent measures (neurocognitive measures) using the general linear model. Bivariate correlation coefficients are presented in Table 3. TCD, chronological age, hematocrit, and gender served as the predictor variables and were entered into the full model. Standardized ß weights for the predictor variables were examined to determine their relative predictive ability.


View this table:
[in this window]
[in a new window]
  		TABLE 3. Bivariate Correlations Between Pedictor and Dependent Variables (N = 44)

 
As shown in Table 4, the full regression model significantly predicted full-scale intellectual functioning (adjusted R2 = 0.19, F[4,36] = 3.29, P < .05), verbal intellectual functioning (adjustedR2 = 0.36, F[4,36] = 6.70, P < .001), reading (adjustedR2 = 0.15, F[4,38] = 2.85, P < .05), sustained attention/concentration (adjustedR2 = 0.19, F[4,37] = 3.34, P < .05), auditory working memory (adjustedR2 = 0.15, F[4,38] = 2.78, P < .05), and executive function (adjustedR2 = 0.31, F[4,32] = 5.08, P < .01). The full regression model accounted for between 15% and 36% of the explained variance in neurocognitive functioning on the various dependent measures. Gender did not account for a significant amount of variance on any of the outcome variables. Age was a significant predictor of full-scale and verbal intellectual functioning, sustained attention/concentration, visual working memory, and executive function, accounting for 41% to 64% of the explained variance for each of these measures. Hematocrit also predicted reading and mathematics achievement, accounting for 27% and 39% of the explained variance on these measures, respectively. Finally, after controlling for age, gender, and hematocrit, TCD predicted auditory working memory, accounting for 41% of the explained variance.


View this table:
[in this window]
[in a new window]
  		TABLE 4. Multiple Regression Analyses Predicting Neurocognitive Functioning

 

   DISCUSSION
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
Our study is the first to examine the relationship between cerebral blood flow velocity, measured by TCD ultrasonography, and neurocognitive functioning in a sample of children with sickle cell anemia (HbSS) and no documented history of CVA. Our investigation offers the additional advantage of examining various domains of cognitive functioning by using psychometric measures and cross-informant (caregivers and teachers) behavioral ratings.

The performance of children classified according to STOP study criteria of normal <170 cm/sec, conditional 170 to 200 cm/sec, and abnormal >200 cm/sec28,29 was compared on measures of intellectual abilities, academic achievement, sustained attention/concentration, executive function, and parent and teacher behavior ratings of executive function. Children with abnormal TCD values performed more poorly than those designated with conditional TCD values on measures of verbal intelligence and executive function. Children with conditional TCD values performed more poorly than participants with normal TCD values on measures of executive function. Children with conditional TCD values also performed more poorly on measures of sustained attention/concentration, although these data must be interpreted with caution given the exploratory nature of the analyses. Preliminary findings also revealed deterioration in neurocognitive performance as a function of chronological age. Specifically, a decline in intellectual abilities, sustained attention/concentration, and executive functions was evidenced with increasing chronological age. Finally, TCD values were a significant predictor of auditory working memory after controlling for age, gender, and hematocrit; again, these data must be interpreted judiciously given the exploratory nature of the analyses.

It should be noted that our findings yielded seemingly inconsistent results. For example, children with abnormal TCD values performed more poorly on measures of global functioning (verbal intelligence and behavioral ratings of executive functions), whereas children with conditional TCD values performed more poorly on measures of specific neurocognitive skills (attention/concentration and executive function). One possible explanation is that participants with conditional TCD values may represent a subgroup of the pediatric SCD population that is distinct from participants with abnormal TCD values. Children with abnormal TCD values may have both vascular and structural abnormalities, whereas children with conditional TCD values may evidence simply one of these abnormalities. This possibility is supported by evidence that TCD and MRI studies often are discordant for children with SCD, perhaps revealing different aspects of the pathophysiology of CNS injury.40,41 In addition, children with abnormal blood flow velocities were the most likely to have been in their respective TCD diagnostic group for the longest period of time. For this reason, they may have experienced the cumulative effects of SCD for a greater duration of time with concomitant global impairment of function. An alternative explanation may relate to the relatively small sample size of this investigation, which may have resulted in sampling error. Regardless of which explanation may be correct, the general finding that elevated TCD values are associated with some type of cognitive impairment is provocative and clearly warrants additional investigation.

The contribution of our investigation must be interpreted within the limitations of the study design. First, the lack of a consistent stepwise increase in neurocognitive and behavioral dysfunction with increasingly high blood flow velocity may be explained, in part, by the confounding influence of transfusion therapy. The performance of the abnormal TCD group in this study was necessarily confounded by the transfusion therapy that they received as part of the National Institutes of Health STOP trial.28,29 Future studies will need to use prospective designs and control for the possible rehabilitative effects of transfusion therapy to determine the influence of this treatment on neurocognitive functioning in the long term. Second, neuroimaging, which was not available for all participants at the time of this investigation, would have permitted identification of participants with structural abnormalities that are characteristic of silent infarcts. Future investigations will need to corroborate TCD and neurocognitive data with neuroimaging techniques, including MRI and magnetic resonance angiography. Finally, the small sample size may have mitigated power and diminished significant effects that otherwise may have been detected with a larger sample. Additional research will need to include multisite, collaborative clinical samples that ensure larger cohorts of children with SCD. Both longitudinal designs and experimental studies are needed to confirm the correlational data obtained in this investigation. Whether there are critical developmental periods for neurocognitive impairment among children with SCD remains to be tested.

Of interest in our investigation is the association between age and neurocognitive decline. Some experts have suggested that SCD may constitute a progressive multisystemic disease process that includes CNS involvement.14 Clearly, additional study of this phenomenon is needed to corroborate these preliminary findings, particularly longitudinal studies that permit the examination of the natural progress of CNS disease during childhood and adolescence.

Notwithstanding these limitations, our data lend support to the growing body of evidence suggesting deficits in sustained attention/concentration and executive function in children with HbSS disease with various stages of CNS pathology.4,7,19 Most important, these results support recent evidence for the sensitivity of measures of specific neurocognitive functions as indices of disease severity, compared with more global measures of intelligence and academic achievement.42 As such, our findings underscore the importance of using measures of sustained attention/concentration and executive function to assess children who have HbSS disease and are at risk for neurologic impairment. In fact, these findings were substantiated for both psychometric measures and cross-informant behavioral ratings; the multiple informants and multiple data sources used in our investigation support the robustness of our findings.

Because we found that children with the most severe cerebrovasculopathy (measured by TCD ultrasonography) evidenced the greatest impairment in neurocognitive functions subserved by the frontal systems (sustained attention/concentration and executive function), we posit that the frontal systems are vulnerable to the effects of progressive pathology in the major cerebral arteries. It remains unclear why this region of the brain seems most vulnerable to insult. However, our findings are consistent with evidence suggesting altered metabolism on positron emission tomography scans in the frontal lobe area of adult patients with SCD.43 Our data also are consistent with the finding of pervasive frontal cortex blood flow dysfunction in adults with HbSS disease, despite structurally normal tissue on MRI.22 For children, cerebrovasculopathy associated with HbSS disease may interfere with the dynamic nature of development in the frontal cortex over time. Clearly, future research efforts will need to investigate the mechanism by which the frontal systems are affected by the progressive nature of cerebrovascular disease in children with SCD.


   ACKNOWLEDGMENTS
 
This research was supported in full by a grant awarded from the National Institutes of Health, National Institute of Neurological Disorders and Stroke, National Research Service Award, F31 NS43181-01. This research was approved by the steering committee of the STOP trial and was supported by cooperative agreements (U10 HL 52193 and U10 HL 52016) with the National Heart, Lung, and Blood Institute.

We thank the following individuals for contributions to this investigation: Jerri Winfrey-Carter and Shannon Johnson, Division of Hematology/Oncology, Medical University of South Carolina; Dr Kathleen McKie, Dr Virgil McKie, Dr Robert Adams, Ivy Tillman, and Heidii Poplick, Department of Pediatrics, Medical College of Georgia; and the patients and their families.


   FOOTNOTES
 
Received for publication Jul 8, 2002; Accepted Dec 5, 2002.

Reprint requests to (M.C.K.) the Division of Genetics and Developmental Pediatrics, Medical University of South Carolina, 135 Rutledge Ave, Box 250561, Charleston, SC 29425. E-mail: kralm{at}musc.edu

a In a series of separate 1-way MANCOVAs in which hematocrit was not treated as a covariate, significant group differences were diminished. Back


   REFERENCES
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cooperative Study of Sickle Cell Disease. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood.1998; 91 :288 –294[Abstract/Free Full Text]
  2. Powars D, Wilson B, Imbus C, Pegelow C, Allen J. The natural history of stroke in sickle cell disease. Am J Med.1978; 65 :461 –471[CrossRef][Web of Science][Medline]
  3. Armstrong FD, Thompson RJ, Wang W, et al. Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Pediatrics.1996; 97 :864 –870[Abstract/Free Full Text]
  4. Brown RT, Davis PC, Lambert R, Hsu L, Hopkins K, Eckman J. Neurocognitive functioning and magnetic resonance imaging in children with sickle cell disease. J Pediatr Psychol.2000; 25 :503 –513[Abstract/Free Full Text]
  5. Cohen MJ, Branch WB, McKie VC, Adams RJ. Neuropsychological impairment in children with sickle cell anemia and cerebrovascular accidents. Clin Pediatr.1994; 33 :517 –524
  6. Craft S, Schatz J, Glauser TA, Lee B, DeBaun MR. Neuropsychologic effects of stroke in children with sickle cell anemia. J Pediatr.1993; 123 :712 –717[CrossRef][Web of Science][Medline]
  7. Schatz J, Craft S, Koby M, et al. Neuropsychological deficits in children with sickle cell disease and cerebral infarction: role of lesion site and location. Child Neuropsychol.1999; 5 :92 –103[CrossRef]
  8. Boni LA, Brown RT, Davis PC, Hsu L, Hopkins K. Social information processing and magnetic resonance imaging in children with sickle cell disease. J Pediatr Psychol.2001; 26 :309 –319[Abstract/Free Full Text]
  9. Hindmarsh PC, Brozovic M, Brook CGD, Davies SC. Incidence of overt and covert neurological damage in children with sickle cell disease. Postgrad Med J.1987; 63 :751 –753[Abstract/Free Full Text]
  10. Moser FG, Miller ST, Bello JA, et al. The spectrum of brain MR abnormalities in sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. AJNR Am J Neuroradiol.1996; 17 :965 –972[Abstract]
  11. Pavlakis SG, Bello J, Prohovnik I, et al. Brain infarction in sickle cell anemia: magnetic resonance imaging correlates. Ann Neurol.1988; 23 :126 –130
  12. Kugler S, Anderson B, Cross D, et al. Abnormal cranial magnetic resonance imaging scans in sickle cell disease: neurological correlates and clinical implications. Arch Neurol.1993; 50 :629 –635[Abstract/Free Full Text]
  13. Wang WC, Langston JW, Steen RG, et al. Abnormalities of the central nervous system in very young children with sickle cell anemia. J Pediatr.1998; 132 :994 –998[CrossRef][Web of Science][Medline]
  14. Brown RT, Buchanan I, Doepke K, et al. Cognitive and academic functioning in children with sickle cell disease. J Clin Child Psychol.1993; 22 :207 –218[CrossRef][Web of Science]
  15. Chapar GN, Doctors SR, Radel E, Coupey SM. Minimal neurological deficits in adolescents with sickle cell disease. J Dev Behav Pediatr.1986; 7 :205
  16. Goonan BT, Goonan LJ, Brown RT, Buchanan I, Eckman JR. Sustained attention and inhibitory control in children with sickle cell syndrome. Arch Clin Neuropsychol.1994; 9 :89 –104[CrossRef][Web of Science][Medline]
  17. Swift AV, Cohen MJ, Hynd GW, et al. Neuropsychologic impairment in children with sickle cell anemia. Pediatrics.1989; 84 :1077 –1085[Abstract/Free Full Text]
  18. Wasserman AL, Wilimas JA, Fairclough DL, Mulhern RK, Wang W. Subtle neuropsychologic deficits in children with sickle cell disease. Am J Pediatr Hematol Oncol.1991; 13 :14 –20[Web of Science][Medline]
  19. DeBaun MR, Schatz J, Siegel MJ, et al. Cognitive screening examinations for silent cerebral infarcts in sickle cell disease. Neurology.1998; 50 :1678 –1682[Abstract/Free Full Text]
  20. Steen RG, Reddick WE, Mulhern RK, et al. Quantitative MRI of the brain in children with sickle cell disease reveals abnormalities unseen by conventional MRI. J Magn Reson Imaging.1998; 8 :535 –543[Web of Science][Medline]
  21. Watkins KE, Hewes DKM, Connelly A, et al. Cognitive deficits associated with frontal-lobe infarction in children with sickle cell disease. Dev Med Child Neurol.1998; 40 :536 –543[Web of Science][Medline]
  22. Prohovnik I, Sano M, DeVivo D, Hurtlet A, Keilp J, Piomelli S. Frontal lobe dysfunction in sickle cell anemia. J Cereb Blood Flow Metab.1995; 15 :S800
  23. Stockman JA, Nigro MA, Mishkin MM, Oski FA. Occlusion of large cerebral vessels in sickle cell anemia. N Engl J Med.1972; 287 :846 –849
  24. Rothman SM, Fulling KH, Nelson JS. Sickle cell anemia and central nervous system infarction: a neuropathological study. Ann Neurol.1986; 20 :684 –690[CrossRef][Web of Science][Medline]
  25. Adams RJ, McKie VC, Carl EM, et al. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurology.1997; 42 :599 –704
  26. Adams R, McKie V, Nicholas F, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med.1992; 326 :605 –610[Abstract]
  27. Adams RJ, Nichols FT, Figueroa R, McKie V, Lott T. Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke.1992; 23 :1073 –1077[Abstract/Free Full Text]
  28. Adams RJ, McKie VC, Brambilla D, et al. Stroke prevention trial in sickle cell anemia. Controlled Clin Trials.1997; 1 :110 –129
  29. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med.1998; 339 :5 –11[Abstract/Free Full Text]
  30. Wechsler D. Wechsler Abbreviated Scale of Intelligence. San Antonio, TX: The Psychological Corporation; 1999
  31. Kaufman AS. Assessing Adolescent and Adult Intelligence. Boston, MA: Allyn & Bacon; 1990
  32. Sattler JM. Assessment of Children: Cognitive Applications. 4th ed. La Mesa, CA: Author; 2001
  33. Wechsler D. Wechsler Abbreviated Scale of Intelligence: Manual. San Antonio, TX: The Psychological Corporation; 1999
  34. Woodcock RW, Johnson MB. Woodcock-Johnson Psycho-Educational Battery—Revised. Allen, TX: DLM Teaching Resources; 1998
  35. Conners CK. Conners’s Continuous Performance Test. 2nd ed. North Tonawanda, NY: MultiHealth Systems; 1995
  36. Cohen MJ. Children’s Memory Scale. San Antonio, TX: The Psychological Corporation; 1997
  37. Riccio CA, Cohen MJ, Hall J, Ross CM. The third and fourth factors of the WISC-III: what they don’t measure. J Psychoeduc Assess.1997; 15 :27 –39
  38. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery. Tucson, AZ: Neuropsychology Press; 1985
  39. Gioia GA, Isquith PK, Guy SC, Kenworthy L. Behavior Rating Inventory of Executive Function. Odessa, FL: Psychological Assessment Resources; 2000
  40. Pegelow CH, Wang W, Granger S, et al. Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity. Arch Neurol.2001; 58 :2017 –2021[Abstract/Free Full Text]
  41. Wang WC, Gallagher DM, Pegelow CH, et al. Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease. J Pediatr Hematol Oncol.2000; 22 :335 –339[CrossRef][Web of Science][Medline]
  42. Schatz J, Finke RL, Kellett JM, Kramer JH. Cognitive functioning in children with sickle cell disease: a meta-analysis. J Pediatr Psychol.2002; 27 :739 –748[Abstract/Free Full Text]
  43. Rodgers GP, Clark CM, Larson SM, Rapoport SI, Nienhuis AW, Schecter AN. Brain glucose metabolism in neurologically normal patients with sickle cell disease: regional alterations. Arch Neurol.1988; 45 :78 –82[Abstract/Free Full Text]
PEDIATRICS (ISSN 1098-4275). ©2003 by the American Academy of Pediatrics

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J Child NeurolHome page
J. Schatz, C. B. McClellan, E. S. Puffer, K. Johnson, and C. W. Roberts
Neurodevelopmental Screening in Toddlers and Early Preschoolers With Sickle Cell Disease
J Child Neurol, January 1, 2008; 23(1): 44 - 50.
[Abstract] [PDF]

Home page
 PediatricsHome page
C. M. Hill, A. M. Hogan, N. Onugha, D. Harrison, S. Cooper, V. J. McGrigor, A. Datta, and F. J. Kirkham
Increased Cerebral Blood Flow Velocity in Children With Mild Sleep-Disordered Breathing: A Possible Association With Abnormal Neuropsychological Function
Pediatrics, October 1, 2006; 118(4): e1100 - e1108.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. J. Strouse, C. S. Cox, E. R. Melhem, H. Lu, M. A. Kraut, A. Razumovsky, K. Yohay, P. C. van Zijl, and J. F. Casella
Inverse correlation between cerebral blood flow measured by continuous arterial spin-labeling (CASL) MRI and neurocognitive function in children with sickle cell anemia (SCA)
Blood, July 1, 2006; 108(1): 379 - 381.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
M. C. Kral, R. T. Brown, J. K. Cure, N. Besenski, S. M. Jackson, and M. R. Abboud
Radiographic Predictors of Neurocognitive Functioning in Pediatric Sickle Cell Disease
J Child Neurol, January 1, 2006; 21(1): 37 - 44.
[Abstract] [PDF]

Home page
 BloodHome page
R. J. Adams, D. J. Brambilla, S. Granger, D. Gallagher, E. Vichinsky, M. R. Abboud, C. H. Pegelow, G. Woods, E. M. Rohde, F. T. Nichols, et al.
Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study
Blood, May 15, 2004; 103(10): 3689 - 3694.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kral, M. C.
Right arrow Articles by Hynd, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kral, M. C.
Right arrow Articles by Hynd, G. W.
Related Collections
Right arrow Blood
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?